| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/12/2013 | WO2013181731A1 Composition and methods for the production of biopolymeric materials that biodegrade rapidly, and are flexible and rigid, with use of the xanthan bioplastic as a component of the biopolymetric matrix and optionally fillers and/or nanofillers and other constituents, the resulting products and the uses thereof |
| 12/12/2013 | WO2013155320A3 Use of microbial gene products to prevent or treat microbial infections |
| 12/12/2013 | WO2013154647A3 Il-12 for radiation protection and radiation-induced toxicity mitigation |
| 12/12/2013 | WO2013108272A3 Blood stage malaria vaccine |
| 12/12/2013 | WO2012140417A3 Combination vaccine against staphyloccal infections |
| 12/12/2013 | WO2012134591A3 Plasmodium falciparum antigens |
| 12/12/2013 | WO2009128950A8 Deletion mutants of flagellin and methods of use |
| 12/12/2013 | US20130333074 Enhancer of cell division |
| 12/12/2013 | US20130331551 Preparation of canola protein isolate from canola oil seeds ("blendertein") |
| 12/12/2013 | US20130331550 Recombinant bacterial lipocalin blc and uses thereof |
| 12/12/2013 | US20130331548 Compositions of flagellin and papillomavirus antigens |
| 12/12/2013 | US20130331547 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury |
| 12/12/2013 | US20130331465 Fluorinated protein-based polymeric carriers |
| 12/12/2013 | US20130331441 Cell Line, System and Method for Optical Control of Secondary Messengers |
| 12/12/2013 | US20130331335 Treatment of cancers with immunostimulatory hiv tat derivative polypeptides |
| 12/12/2013 | US20130331327 Variant Beta2-microglobulin, characterization of the same and applications thereof |
| 12/12/2013 | US20130331325 Chimeric fibroblast growth factor 23 proteins and methods of use |
| 12/12/2013 | US20130331322 Exendins and exendin agonist analogs to regulate gastrointestinal motility |
| 12/12/2013 | US20130331317 Chimeric fibroblast growth factor 19 proteins and methods of use |
| 12/12/2013 | US20130331316 Chimeric fibroblast growth factor 21 proteins and methods of use |
| 12/12/2013 | US20130331315 Protein Hydrolysate Compositions Having Enhanced CCK and GLP-1 Releasing Activity |
| 12/12/2013 | US20130331282 Marker composition comprising s1p protein for prediction of risk in osteoporotic fracture and osteoporosis |
| 12/12/2013 | US20130330820 Use of Molecular Chaperones for the Enhanced Production of Secreted, Recombinant Proteins in Mammalian Cells |
| 12/12/2013 | US20130330819 Use of Molecular Chaperones for the Enhanced Production of Secreted, Recombinant Proteins in Mammalian Cells |
| 12/12/2013 | US20130330773 Macrocyclic compounds with a hybrid peptidic/non-peptidic backbone and methods for their preparation |
| 12/12/2013 | US20130330769 Serpin Fusion Polypeptides And Methods Of Purification Thereof |
| 12/12/2013 | US20130330766 Encryption of adeno-associated viruses with enzymatically decoded peptide locks |
| 12/12/2013 | US20130330744 Nitrated cardiac troponin i as a biomarker of cardiac ischemia |
| 12/12/2013 | US20130330742 Assay for colon and other cancers in humans |
| 12/12/2013 | US20130330718 Proteins that efficiently generate singlet oxygen |
| 12/12/2013 | US20130330414 Methods and compositions for treating inflammation |
| 12/12/2013 | US20130330370 Novel sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof |
| 12/12/2013 | US20130330368 Eye drop composition for prevention and treatment of ophthalmic diseases containing fusion protein of fk506 binding protein |
| 12/12/2013 | US20130330367 Compositions with enhanced immunogenicity and/or reduced reactogenicity |
| 12/12/2013 | US20130330344 Antibody molecules having specificity for human ox40 |
| 12/12/2013 | US20130330340 Production of n- and o-sialylated tnfrii-fc fusion protein in yeast |
| 12/12/2013 | US20130330338 Ctla4 proteins and their uses |
| 12/12/2013 | US20130330336 Fibroblast growth factor 21 proteins |
| 12/12/2013 | US20130330335 Bioinformatic processes for determination of peptide binding |
| 12/12/2013 | US20130330329 B7-h7 antibodies and method of use |
| 12/12/2013 | US20130330321 Injection paradigm for administration of botulinum toxins |
| 12/12/2013 | US20130330314 Metal Abstraction Peptide With Superoxide Dismutase Activity |
| 12/12/2013 | US20130330305 Cytokine derivatives |
| 12/12/2013 | US20130330296 Methods and Compositions Comprising IL-7 Receptor Ligands |
| 12/12/2013 | US20130330294 Serum Amyloid A (SAA) Overrides Regulatory T Cells (TREG) Anergy |
| 12/12/2013 | CA2876135A1 Modified fibronectin fragments or variants and uses thereof |
| 12/12/2013 | CA2875790A1 Chimeric fibroblast growth factor 21 proteins and methods of use |
| 12/12/2013 | CA2874923A1 Peptides derived from viral proteins for use as immunogens and dosage reactants |
| 12/11/2013 | EP2672268A1 Mycobacterium antigens |
| 12/11/2013 | EP2671951A2 Pesticidal genes from Brevibacillus and methods for their use |
| 12/11/2013 | EP2671947A1 Peptide library |
| 12/11/2013 | EP2671890A1 Modulation of TLR4-signaling pathway |
| 12/11/2013 | EP2670847A1 Methods and materials for enhancing functional protein expression in bacteria |
| 12/11/2013 | EP2670774A1 Caspase-2 inhibitors |
| 12/11/2013 | EP2670773A1 Purification of insulin |
| 12/11/2013 | EP2670772A1 Antagonists of grasp55 for use as a medicament |
| 12/11/2013 | EP2670771A1 Antinematodal methods and compositions |
| 12/11/2013 | EP2670770A2 High molecular ordered fibrilar structures, method for their preparation and uses thereof |
| 12/11/2013 | EP2670769A1 R2r1/2 in diagnosis and therapy |
| 12/11/2013 | EP2670768A1 Polyvinyl chloride surface co-immobilized with enzymes and uses thereof |
| 12/11/2013 | EP2670767A1 Unnatural amino acids comprising a cyclooctynyl or trans-cyclooctenyl analog group and uses thereof |
| 12/11/2013 | EP2670432A1 Immunogenic bordetella bronchiseptica compositions |
| 12/11/2013 | EP2670430A2 Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza a viruses |
| 12/11/2013 | EP2670426A2 Multimodal trail molecules and uses in cellular therapies |
| 12/11/2013 | EP2670424A2 Cardiotrophin related molecules for enhanced therapeutics |
| 12/11/2013 | EP2670416A1 A novel high affinity bivalent helically constrained peptide against cancer |
| 12/11/2013 | EP2670256A1 Aerated food products |
| 12/11/2013 | EP2650371A9 Method for the microbial production of organic acids, other molecules and bioactive substances from bioplastic materials |
| 12/11/2013 | EP2133427B1 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby |
| 12/11/2013 | EP1711533B1 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby |
| 12/11/2013 | CN203329679U Stirrer used in production process of collagen |
| 12/11/2013 | CN1798574B Acapsular p. multocida hyae deletion mutants |
| 12/11/2013 | CN103443627A Test kit for plasma or serum antibody titer against periodontal disease-ausing bacteria |
| 12/11/2013 | CN103443265A Compositions and methods for separating, characterizing and administering soluble selenoglycoproteins |
| 12/11/2013 | CN103443124A Il-21 ligands |
| 12/11/2013 | CN103443123A Lipoprotein complexes and manufacturing and uses thereof |
| 12/11/2013 | CN103443121A Novel coelenterazine substrates, and methods of use the coelenterazine substrates |
| 12/11/2013 | CN103443120A Novel immunoglobulin-binding polypeptide |
| 12/11/2013 | CN103443117A Aptamer-modified polymeric materials for the binding of therapeutic factors in a wound environment |
| 12/11/2013 | CN103442676A Composition comprising peroxisome proliferator-activated receptor-gamma |
| 12/11/2013 | CN103436574A Use of human cells of myeloid leukaemia origin for expression of antibodies |
| 12/11/2013 | CN103436552A Production method and application of human-derived annexin A2 |
| 12/11/2013 | CN103436542A Cellulase and hemicellulase activity factor as well as expressed gene and application thereof |
| 12/11/2013 | CN103436541A Populus deltoides*Populus nigraPdHARDY gene and application thereof |
| 12/11/2013 | CN103436540A Apocynum venetum eIF-5A gene and encoded protein thereof |
| 12/11/2013 | CN103436539A Vetiver aquaporin gene VzPIP2-1 and plant expression carrier and applications thereof |
| 12/11/2013 | CN103436538A Antimicrobial peptide as well as preparation method and application thereof |
| 12/11/2013 | CN103436537A Lily ester floral gene LoAAT1 and application thereof |
| 12/11/2013 | CN103436536A Peanut FUS3 transcription factor gene, and encoding protein and application of peanut FUS3 transcription factor gene |
| 12/11/2013 | CN103436535A Nitrate transporter gene AtNRT1.5, and coding protein and application thereof |
| 12/11/2013 | CN103436507A Phage derived antimicrobial activities |
| 12/11/2013 | CN103435698A Sclerostin结合剂 Sclerostin binding agents |
| 12/11/2013 | CN103435694A Smoothened多肽及使用方法 Smoothened polypeptide and methods of use |
| 12/11/2013 | CN103435693A Ovomucin composite solubilizer and solubilization method of ovomucin |
| 12/11/2013 | CN103435692A Application of ginseng glycoprotein in medicaments and health-care foods for treating senile dementia |
| 12/11/2013 | CN103435691A TALE (Transcription Activator Like Effectors) protein and application thereof |
| 12/11/2013 | CN103435690A DNA (deoxyribonucleic acid) vaccine of HCV (hepatitis C virus) and preparation method thereof |
| 12/11/2013 | CN103435689A Molecular chaperone TSPcpn47 and polynucleotide encoding same |
| 12/11/2013 | CN103433484A Bovine serum albumin-platinum composite nanomaterial mimetic peroxidase |
| 12/11/2013 | CN103432568A Activin-ActRIIa antagonists and uses for promoting bone growth |